Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51134-92-0

Post Buying Request

51134-92-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-[5-[[3-CARBOXY-2,4,6-TRIIODO-5-[(2-OXOPYRROLIDIN-1-YL)METHYL]PHENYL]CARBAMOYL]PENTANOYLAMINO]-2,4,6-TRIIODO-5-[(2-OXOPYRROLIDIN-1-YL)METHYL]BENZOIC ACID

    Cas No: 51134-92-0

  • No Data

  • No Data

  • No Data

  • Hangzhou Fandachem Co.,Ltd
  • Contact Supplier

51134-92-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 51134-92-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,1,3 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 51134-92:
(7*5)+(6*1)+(5*1)+(4*3)+(3*4)+(2*9)+(1*2)=90
90 % 10 = 0
So 51134-92-0 is a valid CAS Registry Number.

51134-92-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[[6-[3-carboxy-2,4,6-triiodo-5-[(2-oxopyrrolidin-1-yl)methyl]anilino]-6-oxohexanoyl]amino]-2,4,6-triiodo-5-[(2-oxopyrrolidin-1-yl)methyl]benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51134-92-0 SDS

51134-92-0Upstream product

51134-92-0Downstream Products

51134-92-0Relevant articles and documents

Radiopaque contrast media. XXIV. Synthesis and structure activity relationships of new hexaiodinated radiopaque compounds

Felder,Pitre,Fumagalli,Lorenzotti

, p. 912 - 924 (2007/10/06)

The synthesis of a series of new hexaiodinated radiopaque compounds is described. The relationship of structure to tolerability and biliary and urinary excretion was studied. Optimum tolerability was achieved with a compound which has been selected for further investigation as an angiographic contrast agent of the 'dimer' type. Iodoxamic acid showed a high biliary excretion combined with good tolerability, and is being developed as an injectable cholecystographic agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51134-92-0